First domestic-made erectile dysfunction drug debuts in China

19 September 2014

A Chinese pharmaceutical company on Thursday launched the country's first domestic-made erectile dysfunction treatment drug, aiming to challenge foreign domination of this market, reports the state-owned news service Xinhua.

The pill, called Jinge, is made by Guangzhou Bai Yun Shan Pharmaceutical General Factory in south China's Guangdong Province. The company will sell the drug nationwide from late October, hoping to rake in up to one billion renminbi ($160 million) in revenues in the next few years.

The price of Jinge will be a fraction of that of foreign pills, according to the drug's maker. A subsidiary of Bai Yun Shan can produce materials used to make the drug, Xinhua reported.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical